CA Stock MarketDetailed Quotes
QNTM Quantum BioPharma Ltd
- 5.390
- +0.650+13.71%
15min DelayTrading Dec 27 10:35 ET
10.35MMarket Cap-0.30P/E (TTM)
5.770High5.100Low8.17KVolume5.100Open4.740Pre Close44.25KTurnover12.22052wk High0.51%Turnover Ratio1.92MShares3.90052wk Low-17.832EPS TTM8.60MFloat Cap12.220Historical HighLossP/E (Static)1.59MShs Float3.900Historical Low-39.637EPS LYR14.14%Amplitude--Dividend TTM0.44P/B1Lot Size--Div YieldTTM
About Quantum BioPharma Ltd Company
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
Company Profile
SymbolQNTM
Company NameQuantum BioPharma Ltd
Founded1994
MarketCNQ
Employees8
Fiscal Year Ends12-31
Address199 Bay Street Suite 4000
CityToronto
CountryCAN
Zip CodeM5L 1A9
Phone+1 416 854-8884
Websitehttps://www.fsdpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Lakshmi P. Kotra
- Chief Executive Officer, Lucid Psycheceuticals Inc. and FSD Australia; Director
- 521.97K
- Zeeshan Saeed
- Chief Executive Officer, Co-Executive Chairman of the Board and President
- 599.87K
- Donal Carroll
- Chief Operating Officer
- 602.87K
- Nathan Coyle
- Chief Financial Officer
- 178.21K
- Anthony Durkacz
- Executive Co-Chairman of the Board
- 599.87K
- Michael Zapolin
- Independent Director
- 126.00K
- Adnan Bashir
- Independent Director
- 139.37K
- Dr. Eric Hoskins
- Independent Director
- --
- Sanjiv Chopra
- Independent Director
- --
Heat List
CA
Overall
Symbol
Price
% Chg
No Data